NCT02547792View on ClinicalTrials.gov

Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 20, 2015

Primary Completion Date

November 21, 2016

Study Completion Date

November 21, 2016

Conditions
Seasonal Influenza B
Interventions
BIOLOGICAL

VXA-BYW.10 (Low Dose) Oral Vaccine

Enteric coated tablet for oral delivery

BIOLOGICAL

VXA-BYW.10 (High Dose) Oral Vaccine

Enteric coated tablet for oral delivery

OTHER

Placebo Tablets

Enteric coated tablet for oral delivery

Trial Locations (1)

8011

CCST, Christchurch

Sponsors

Lead Sponsor

Vaxart
All Listed Sponsors
lead

Vaxart

INDUSTRY

NCT02547792 - Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults | Biotech Hunter | Biotech Hunter